Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study

Tomas Urbina, Florence Canoui-Poitrine, Camille Hua, Richard Layese, Aline Alves, Rachida Ouedraogo, Romain Bosc, Emilie Sbidian, Olivier Chosidow, Armand Mekontso Dessap, Nicolas de Prost, Henri Mondor Hospital Necrotizing Fasciitis Group, Romain Bosc, Olivier Chosidow, Nicolas de Prost, Camille Hua, Raphaël Lepeule, Alain Luciani, Lionel Nakad, Françoise Tomberli, Tomas Urbina, Paul-Louis Woerther, Tomas Urbina, Florence Canoui-Poitrine, Camille Hua, Richard Layese, Aline Alves, Rachida Ouedraogo, Romain Bosc, Emilie Sbidian, Olivier Chosidow, Armand Mekontso Dessap, Nicolas de Prost, Henri Mondor Hospital Necrotizing Fasciitis Group, Romain Bosc, Olivier Chosidow, Nicolas de Prost, Camille Hua, Raphaël Lepeule, Alain Luciani, Lionel Nakad, Françoise Tomberli, Tomas Urbina, Paul-Louis Woerther

Abstract

Background: Compared to other life-threatening infection survivors, long-term health-related quality of life (QOL) of patients surviving necrotizing soft-tissue infections (NSTI) and its determinants are little known. In this monocentric prospective cohort including NSTI survivors admitted between 2014 and 2017, QOL was assessed during a phone interview using the 36-Item Short-Form Health Survey (SF-36), the Hospital Anxiety and Depression (HAD), the activity of daily living (ADL), instrumental ADL (IADL) scales and the Impact of Event Scale-Revised (IES-R). The primary outcome measure was the SF-36 physical component summary (PCS). NSTI patients were compared according to intensive care unit (ICU) admission status. ICU survivors were matched on SAPS II with non-NSTI related septic shock survivors.

Results: Forty-nine NSTI survivors were phone-interviewed and included in the study. Median PCS was decreased compared to the reference population [- 0.97 (- 2.27; - 0.08) SD]. Previous cardiac disease was the only variable associated with PCS alteration [multivariate regression coefficient: - 8.86 (- 17.64; - 0.07), p = 0.048]. Of NSTI survivors, 15.2% had a HAD-D score ≥ 5 and 61.2% an IES-R score ≥ 33. ICU admission was not associated with lower PCS [35.21 (25.49-46.54) versus (vs) 41.82 (24.12-51.01), p = 0.516], but with higher IES-R score [14 (7.5-34) vs 7 (3-18), p = 0.035] and a higher proportion of HAD-D score ≥ 5 (28.6 vs 4.0%, p = 0.036). Compared to non-NSTI septic shock-matched controls, NSTI patients had similar PCS [33.81 (24.58; - 44.39) vs 44.87 (26.71; - 56.01), p = 0.706] but higher HAD-D [3.5 (1-7) vs 3 (1.5-6), p = 0.048] and IES-R scores [18 (8-35) vs 8 (3-19), p = 0.049].

Conclusions: Long-term QOL in NSTI survivors is severely impaired, similarly to that of non-NSTI septic shock patients for physical compartments, but with more frequent depressive and/or post-traumatic stress disorders. Only ICU admission and previous cardiac disease were predictive of QOL impairment.

Keywords: Critical care; Intensive care unit; Necrotizing fasciitis; Necrotizing soft-tissue infection; Outcome; Quality of life; SF-36; Septic shock.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study flowchart. Necrotizing soft tissue infection (NSTI) survivors (n  =  49) admitted (n  =  24) or not (n  =  25) to the intensive care unit (ICU) were included in the study. First, association of admission characteristics to the long-term health-related quality of life (QOL) of all NSTI survivors was assessed. Then, in order to explore the impact of both NSTI itself and of ICU admission on QOL, NSTI patients admitted to the ICU (n  =  24) were compared to: (1) non-ICU-admitted (n  =  25) NSTI patients; and (2) ICU-admitted non-NSTI septic shock patients (n  =  32) after SAPS II matching. The 24 NSTI patients admitted to the ICU were matched according to SAPS II on a 1:1 ratio for 10 patients and a 1:2 ratio for 11 patients, with 3 patients finding no match, to a total of 32 non-NSTI septic shock patients
Fig. 2
Fig. 2
SF-36 questionnaire results in exposed (ICU-admitted NSTI survivors) and non-exposed (non-NSTI septic shock survivors) patients. A Comparison of the physical (PCS) and mental (PCS) component summaries of the SF-36 questionnaire between patients surviving necrotizing soft tissue infections (“ICU-admitted NSTI”, dark blue) and patients surviving a septic shock from other cause (“non-NSTI septic shock”, light blue). Results are centered on the value of 50 (dashed line; values  >  or  <  50 reflected values higher or lower than age-sex standardized French values). *p values come from a mixed logistic regression with adjustment for sex, SAPS II and the time between ICU discharge and phone interview, with pair as a random effect. B Comparison of each subdomain of the SF-36 questionnaire between patients surviving necrotizing soft tissue infections (“ICU-admitted NSTI”, dark blue) and patients surviving a septic shock from other cause (“non-NSTI septic shock”, light blue). The “physical functioning”, “role physical”, “bodily pain”, and “general health” subdimensions pertain to the PCS aggregate component, the “vitality”, “social functioning”, “mental health”, and “role emotional” subdimensions pertain to the MCS aggregate component. *Stands for statistical significance with p value  <  0.05 from comparing between groups the standard deviations of each score standardized for age and sex, by mixed logistic regression adjusted for sex, age and the time between ICU discharge and phone interview, with pair as a random effect. NSTI necrotizing soft-tissue infection; MCS mental component summary; PCS physical component summary; SF-36 36-Item Short-Form Health Survey
Fig. 3
Fig. 3
SF-36 questionnaire results in NSTI survivors admitted (black) or not admitted (gray) to the ICU. A Comparison of the physical (PCS) and mental (PCS) component summaries of the SF-36 questionnaire between patients surviving necrotizing soft tissue infections admitted (“ICU-admitted NSTI”, black) or non-admitted to the ICU (“non-ICU-admitted NSTI”, gray). Results are centered on the value of 50 (dashed line; values  >  or  <  50 reflected values higher or lower than age-sex standardized French values).*p values come from comparing between groups the standard deviations of each score standardized for age and sex. B Comparison of each subdomain of the SF-36 between patients surviving necrotizing soft tissue infections admitted (“ICU-admitted NSTI”, black) or non-admitted to the ICU (“non-ICU-admitted NSTI”, gray). The “Physical functioning”, “role physical”, “bodily pain”, and “general health” subdimensions pertain to the PCS aggregate component, the “vitality”, “social functioning”, “mental health”, and “role emotional” subdimensions pertain to the MCS aggregate component. *Stands for statistical significance with p value  <  0.05 from comparing between groups the standard deviations of each score standardized for age and sex. MCS mental component summary; PCS physical component summary; SF-36 36-Item Short-Form Health Survey; ICU intensive care unit

References

    1. Al-Qurayshi Z, Nichols RL, Killackey MT, Kandil E. Mortality risk in necrotizing fasciitis: national prevalence, trend, and burden. Surg Infect. 2020 doi: 10.1089/sur.2019.277.
    1. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52. doi: 10.1093/cid/ciu296.
    1. Urbina T, Madsen MB, de Prost N. Understanding necrotizing soft tissue infections in the intensive care unit. Intensiv Care Med. 2020;46:1739–42. doi: 10.1007/s00134-020-06071-w.
    1. Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2019;26:8. doi: 10.1016/j.cmi.2019.06.031.
    1. Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, INFECT Study Group et al. Patient’s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensiv Care Med. 2019;45:1241–51. doi: 10.1007/s00134-019-05730-x.
    1. Urbina T, Hua C, Sbidian E, Bosc R, Tomberli F, Lepeule R, et al. Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study. Ann Intensiv Care. 2019;9:123. doi: 10.1186/s13613-019-0598-4.
    1. Pham TN, Moore ML, Costa BA, Cuschieri J, Klein MB. Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res. 2009;30:301–6. doi: 10.1097/BCR.0b013e318198a241.
    1. Gawaziuk JP, Strazar R, Cristall N, Logsetty S. Factors predicting health-related quality of life following necrotizing fasciitis. J Plast Reconstr Aesthet Surg. 2018;71:857–62. doi: 10.1016/j.bjps.2018.01.035.
    1. Kruppa C, Hutter DJ, Königshausen M, Gessmann J, Schildhauer TA, Coulibaly MO. Necrotizing fasciitis and the midterm outcomes after survival. SAGE Open Med. 2019;7:205031211984243. doi: 10.1177/2050312119842433.
    1. Ehooman F, Biard L, Lemiale V, Contou D, de Prost N, Mokart D, et al. Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study. Ann Intensive Care. 2019;9:2. doi: 10.1186/s13613-018-0478-3.
    1. Nannan Panday RS, Minderhoud TC, Chantalou DS, Alam N, Nanayakkara PWB. Health related quality of life in sepsis survivors from the prehospital antibiotics against sepsis (PHANTASi) trial. PLOS ONE. 2019;14:e0222450. doi: 10.1371/journal.pone.0222450.
    1. Apfelbacher C, Brandstetter S, Blecha S, Dodoo-Schittko F, Brandl M, The DACAPO Study Group et al. Influence of quality of intensive care on quality of life/return to work in survivors of the acute respiratory distress syndrome: prospective observational patient cohort study (DACAPO) BMC Public Health. 2020;20:861. doi: 10.1186/s12889-020-08943-8.
    1. Czymek R, Kujath P, Bruch H-P, Pfeiffer D, Nebrig M, Seehofer D, et al. Treatment, outcome and quality of life after Fournier’s gangrene: a multicentre study. Colorectal Dis. 2013;15:1529–36. doi: 10.1111/codi.12396.
    1. Katz S. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914. doi: 10.1001/jama.1963.03060120024016.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Nurs Res. 1970;19(3):278. doi: 10.1097/00006199-197005000-00029.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Weiss DS, Marmar CR. The impact of event scale—revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. New York: The Guilford Press; 1997. pp. 399–411.
    1. Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, et al. Long-term quality of life in adult patients surviving Purpura fulminans: an exposed-unexposed multicenter cohort study. Clin Infect Dis. 2019;69:332–40. doi: 10.1093/cid/ciy901.
    1. American College of Surgeons, Committee on Trauma . Advanced trauma life support: student course manual. Chicago: American College of Surgeons; 2018.
    1. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63. doi: 10.1097/00005650-199303000-00006.
    1. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JPA. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ. 2009;338:a3006. doi: 10.1136/bmj.a3006.
    1. Torrance N, Smith BH, Lee AJ, Aucott L, Cardy A, Bennett MI. Analysing the SF-36 in population-based research. A comparison of methods of statistical approaches using chronic pain as an example. J Eval Clin Pract. 2009;15:328–34. doi: 10.1111/j.1365-2753.2008.01006.x.
    1. Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51:1013–23. doi: 10.1016/S0895-4356(98)00093-6.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83. doi: 10.1097/00005650-199206000-00002.
    1. Suijker J, de Vries A, de Jong VM, Schepers T, Ponsen KJ, Halm JA. Health-related quality of life is decreased after necrotizing soft-tissue infections. J Surg Res. 2020;245:516–22. doi: 10.1016/j.jss.2019.07.097.
    1. Hakkarainen TW, Burkette Ikebata N, Bulger E, Evans HL. Moving beyond survival as a measure of success: understanding the patient experience of necrotizing soft-tissue infections. J Surg Res. 2014;192:143–9. doi: 10.1016/j.jss.2014.05.006.
    1. Fagerdahl A-M, Knudsen VE, Egerod I, Andersson AE. Patient experience of necrotising soft-tissue infection from diagnosis to six months after intensive care unit stay: a qualitative content analysis. Aust Crit Care. 2020;33:187–92. doi: 10.1016/j.aucc.2019.02.001.
    1. Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, et al. Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients. Br J Dermatol. 2020;182:916–26. doi: 10.1111/bjd.18387.
    1. Pikturnaite J, Soldin M. Impact of necrotising fasciitis on quality of life: a qualitative analysis. Burns. 2014;40:848–51. doi: 10.1016/j.burns.2013.10.016.
    1. Chevet-Noël A, Andreoletti JB, Kheloufi M, Pluvy I. Atteinte des membres dans les DHBN-FN : étude bicentrique entre 2000 et 2017 sur la qualité de vie et impact fonctionnel. Ann Chir Plast Esthét. 2020;65:228–35. doi: 10.1016/j.anplas.2019.05.003.
    1. Brengard-Bresler T, De Runz A, Bourhis F, Mezzine H, Khairallah G, Younes M, et al. Postoperative quality of life of patients with a bacterial necrotizing dermis-hypodermitis or necrotizing fasciitis, a ten-year study. Ann Chir Plast Esthet. 2017;62:31–44. doi: 10.1016/j.anplas.2016.02.001.

Source: PubMed

3
Abonnieren